Skip to main content
Caplight Logo









Oncosoft

Oncosoft

Private
SeoulHealthcare & Life Scienceshttps://oncosoft.io/

Last Round

VC Round

Jul 2, 2026

Total Funding Raised

$10.66M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Oncosoft is a medical technology company that develops AI-based software solutions for radiation oncology, including automated organ contouring and radiotherapy workflow management.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

radiation oncologyauto-contouringmedical imaging AIradiotherapy planningclinical AIworkflow automationdigital healthhealth techDICOMHL7 FHIRFHIRradiopharmaceutical therapyparticle therapymedical softwareSaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oncosoft Comparables

Compare Oncosoft with similar companies based on industry and business-model similarity.

Oncosoft comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MVision AI
92%
TheraPanacea
91%
Synaptiq
90%

Oncosoft Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 2, 2026
Series BSep 23, 2024
Series ASep 1, 2022
VC RoundJul 1, 2021
SeedOct 1, 2020

Oncosoft Investors

Notable investors and investment history

Oncosoft investors
InvestorRounds
BNH INVESTMENTSeries B
Korea Investment & SecuritiesVC Round
Comes InvestmentVC Round
BonAngels Venture PartnersSeries B
WantedLab PartnersVC Round
G.N.Tech Venture CapitalVC Round
HB InvestmentVC Round, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2026

    $10.4M round with participation from Devsisters Ventures.

  • Apr 16, 2025

    Grew 18% QoQ from 17 to 20 employees.

Oncosoft Filings

Explore SEC and related filing metadata, where available.

Oncosoft filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Oncosoft's valuation, stock price, and market status.

Is Oncosoft a public or private company?

Oncosoft is a private company.

What is the current stock price of Oncosoft?

Oncosoft is a private company with no public stock price. No recent secondary market data is available.

How much is Oncosoft worth (valuation)?

Valuation information for Oncosoft is not publicly available.

Can I buy Oncosoft stock?

Oncosoft shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Oncosoft's last funding round?

Oncosoft's most recent funding round was VC Round on July 2, 2026.

Who are the main investors in Oncosoft?

Key investors in Oncosoft include BNH INVESTMENT, HB Investment.

Will Oncosoft IPO soon?

No public IPO plans have been announced for Oncosoft.

How can I track Oncosoft secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oncosoft's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range12
Year Founded2019
Last FundingJul 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?